Kidney transplantation using complement inhibitor in a patient suffering from atypical hemolytic-uremic syndrome associated with factor H antibodies: successful prevention of recurrence of the underlying disease

Atypical hemolytic-uremic syndrome (aHUS) is an extremely rare complement-mediated disease that belongs to the group of thrombotic microangiopathies (TMA). It often reoccurs after kidney transplantation (KT). Previously, KT was considered contraindicated in both children and adults with aHUS due to...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: E. I. Prokopenko, S. A. Pasov, A. V. Vatazin, A. Ya. Tsalman, T. E. Pankratenko, G. A. Generalova
Aineistotyyppi: Artigo
Kieli:Russo
Julkaistu: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2020-07-01
Sarja:Vestnik Transplantologii i Iskusstvennyh Organov
Aiheet:
atypical hemolytic-uremic syndrome
eculizumab
kidney transplantation
complement-activating conditions
Linkit:https://journal.transpl.ru/vtio/article/view/1194
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia